Escalon Medical Corp (ESMC.O) Company Profile | Reuters.com
Edition:
United States

Profile: Escalon Medical Corp (ESMC.O)

ESMC.O on Consolidated Issue listed on NASDAQ Capital Market

0.76USD
24 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,616
52-wk High
$1.55
52-wk Low
$0.70

Escalon Medical Corp. (Escalon), incorporated on September 27, 2001, operates in the healthcare market, engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company operates in two segments: Sonomed-Escalon and Escalon Medical Corp. (Corporate). The Sonomed-Escalon segment includes Sonomed, Inc., Escalon Digital Solutions, Inc. (EMI) and Trek, Inc. (Trek), which are engaged in the development and sale of ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations.

The Company's A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. The principal echoes occur at the cornea, both surfaces of the lens and the retina. The system displays the position and magnitudes of the echoes on an electronic display. The A-Scan also includes software for measuring distances within the eye. This information is used to calculate lens power for implants.

The B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. Whereas physicians normally use light, which cannot pass through such media, the ultrasound beam is capable of passing through the opacity and displaying an image of the internal structures of the eye. Unlike the A-Scan, the B-Scan transducer is not in a fixed position, and it swings through a 60 degree sector to provide a two-dimensional image of the eye. The UBM is a high frequency/high resolution ultrasound device, designed to provide information about the anterior segment of the eye. The UBM is used for glaucoma evaluation, tumor evaluation and differentiation, pre- and post-intraocular lens implantation and corneal refractive surgery. The device allows the surgeons to perform measurements within the anterior chamber of the eye.

The pachymeter uses the same principles as the A-Scan, but the system is tailored to measure the thickness of the cornea. The color/fluorescein angiography (CFA) digital imaging system is designed for ophthalmology. This diagnostic tool is for use in detecting retinal problems in diabetic and elderly patients, and provides an image. The image display provides users with the clinical information that allows treatment to be performed while the patient is still in the physician's office.

The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. Under a non-exclusive distribution agreement with Scott Medical Products (Scott), the Company distributes packages of Scott gases in canisters containing up to 25 grams of gas. Along with the intraocular gases, the Company manufactures and distributes a disposable universal gas kit, which delivers the gas from the canister to the patient. The Company markets viscous fluid transfer systems and related disposable syringe products, which aid surgeons in the process of injecting and extracting silicone oil. Adjustable pressures and vacuums provided by the equipment allow surgeons to manipulate the flow of silicone oil during surgery. Light source and fiber optic products are used by vitreoretinal surgeons during surgery. The Company offers surgeons a line of light sources along with a variety of fiber optic probes and illuminated tissue manipulators. The AXIS Image management system manages images through the Web from any device.

The development of ultrasound ophthalmic equipment is performed at the Company's Lake Success, New York and Stoneham, Massachusetts facilities. The Company leases approximately 11,250 square feet of space in Wisconsin, for its surgical products. Its wholly owned subsidiaries include Sonomed, Inc. (Sonomed), Trek, Inc., Escalon Digital Solutions, Inc. (EMI), Escalon Holdings, Inc. (EHI), Escalon IP Holdings, Inc., Sonomed IP Holdings, Inc. and Drew Scientific Group, Plc (Drew).

The Company competes with Bausch & Lomb, Inc., Alcon Laboratories, Inc., Paradigm Medical, Inc., Quantel, Inc. and Accutome, Inc.

Company Address

Escalon Medical Corp

Suite 200, 100 Church Street
ARDMORE   PA   19003
P: +1610.6886830
F: +1610.6883641

Company Web Links